Kumar Guarve

611 total citations
53 papers, 374 citations indexed

About

Kumar Guarve is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Kumar Guarve has authored 53 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmaceutical Science, 14 papers in Molecular Biology and 8 papers in Biomaterials. Recurrent topics in Kumar Guarve's work include Drug Solubulity and Delivery Systems (11 papers), Advanced Drug Delivery Systems (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Kumar Guarve is often cited by papers focused on Drug Solubulity and Delivery Systems (11 papers), Advanced Drug Delivery Systems (7 papers) and Nanoparticle-Based Drug Delivery (6 papers). Kumar Guarve collaborates with scholars based in India and Australia. Kumar Guarve's co-authors include Priyanka Kriplani, Ajmer Singh Grewal, Bhawna Chopra, Ashwani K. Dhingra, Uttam Singh Baghel, Vishal Bhatia, Ghanshyam Das Gupta, Sukhbir Singh, Prateek Sharma and Neelam Sharma and has published in prestigious journals such as Journal of Pharmacy and Pharmacology, Pharmaceutics and Mini-Reviews in Medicinal Chemistry.

In The Last Decade

Kumar Guarve

45 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kumar Guarve India 11 112 82 67 60 37 53 374
Trilochan Satapathy India 13 123 1.1× 88 1.1× 79 1.2× 30 0.5× 34 0.9× 83 470
Chandra Kala India 10 105 0.9× 97 1.2× 59 0.9× 43 0.7× 43 1.2× 29 402
Navdeep Raghuwanshi India 9 121 1.1× 65 0.8× 39 0.6× 61 1.0× 87 2.4× 16 472
Abubaker M. Hamad Saudi Arabia 15 118 1.1× 55 0.7× 71 1.1× 55 0.9× 31 0.8× 30 436
Usama Ahmad India 11 100 0.9× 81 1.0× 47 0.7× 52 0.9× 49 1.3× 38 372
Neetesh Kumar Jain India 11 86 0.8× 109 1.3× 61 0.9× 41 0.7× 34 0.9× 43 352
Nabeela Ameer Pakistan 9 93 0.8× 61 0.7× 70 1.0× 52 0.9× 63 1.7× 23 407
Arya Kadukkattil Ramanunny India 12 102 0.9× 108 1.3× 56 0.8× 59 1.0× 28 0.8× 20 464
Shehla Nasar Mir Najib Ullah Saudi Arabia 12 113 1.0× 105 1.3× 48 0.7× 52 0.9× 67 1.8× 35 422
Hina Anwar Pakistan 7 216 1.9× 60 0.7× 40 0.6× 67 1.1× 58 1.6× 15 515

Countries citing papers authored by Kumar Guarve

Since Specialization
Citations

This map shows the geographic impact of Kumar Guarve's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kumar Guarve with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kumar Guarve more than expected).

Fields of papers citing papers by Kumar Guarve

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kumar Guarve. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kumar Guarve. The network helps show where Kumar Guarve may publish in the future.

Co-authorship network of co-authors of Kumar Guarve

This figure shows the co-authorship network connecting the top 25 collaborators of Kumar Guarve. A scholar is included among the top collaborators of Kumar Guarve based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kumar Guarve. Kumar Guarve is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grewal, Ajmer Singh, et al.. (2025). Phytoextracts as Natural Anti-Aging Agents: Mechanisms and Strategiesfor Skin Rejuvenation. Current Aging Science. 18. 2 indexed citations
2.
Garg, Madhukar, et al.. (2024). Decoding Therapeutic Applications of Quercetin: Recent Advancements in Nanotechnological Strategies. Pharmaceutical Nanotechnology. 13(4). 596–617. 1 indexed citations
3.
Guarve, Kumar, et al.. (2024). Edible Vaccines: A Patent-Driven Exploration of Immunization Technologies. Recent Patents on Biotechnology. 19(2). 99–112.
4.
Sharma, Prerna, et al.. (2024). Exploring the Therapeutic Potential of Phytoconstituents for AddressingNeurodegenerative Disorders. Central Nervous System Agents in Medicinal Chemistry. 24(2). 129–144. 3 indexed citations
5.
Guarve, Kumar, et al.. (2024). Development of Mycobacterium tuberculosis Enoyl Acyl Reductase (InhA)Inhibitors: A Mini-Review. Mini-Reviews in Medicinal Chemistry. 25(3). 219–233.
6.
7.
Rani, Nidhi, et al.. (2023). Enhanced Solubility and Increased Bioavailability with EngineeredNanocrystals. Current Drug Therapy. 19(6). 638–647. 5 indexed citations
8.
Dhingra, Ashwani K., et al.. (2022). Formulation and Evaluation of Solid Dispersions of Poorly Water-Soluble Drug- Hesperidin. Letters in Applied NanoBioScience. 12(2). 50–50. 6 indexed citations
9.
Dhingra, Ashwani K., Vishal Bhatia, Bhawna Chopra, & Kumar Guarve. (2022). A Review of Clinical Studies Assessing the Therapeutic Efficacy ofEscitalopram: A Step Towards Development. CNS & Neurological Disorders - Drug Targets. 22(1). 41–50. 1 indexed citations
10.
Sharma, Prateek, et al.. (2022). Targeting human Glucokinase for the treatment of type 2 diabetes: an overview of allosteric Glucokinase activators. Journal of Diabetes & Metabolic Disorders. 21(1). 1129–1137. 18 indexed citations
11.
Bhatia, Vishal, Ashwani K. Dhingra, Bhawna Chopra, & Kumar Guarve. (2022). Co-processed excipients: Recent advances and future perspective. Journal of Drug Delivery Science and Technology. 71. 103316–103316. 26 indexed citations
12.
Dutt, Rohit, et al.. (2022). An Electronic Evaluation of Symptoms in People of India Post-COVID-19Vaccination. Current Drug Safety. 18(1). 51–61. 1 indexed citations
13.
Chopra, Bhawna, et al.. (2022). In silico docking based screening of constituents from Persian shallot as modulators of human glucokinase. Journal of Diabetes & Metabolic Disorders. 22(1). 547–570. 3 indexed citations
14.
Kriplani, Priyanka & Kumar Guarve. (2021). Eudragit, a Nifty Polymer for Anticancer Preparations: A Patent Review. Recent Patents on Anti-Cancer Drug Discovery. 17(1). 92–101. 14 indexed citations
15.
Guarve, Kumar, et al.. (2020). Novel Coronavirus 2019 Outbreak: A Global Epidemic. Letters in Drug Design & Discovery. 17(12). 1458–1464. 4 indexed citations
16.
Kriplani, Priyanka, Kumar Guarve, & Uttam Singh Baghel. (2020). Formulation optimization and characterization of transdermal film of curcumin by response surface methodology. Chinese Herbal Medicines. 13(2). 274–285. 14 indexed citations
17.
Kriplani, Priyanka & Kumar Guarve. (2020). Physicochemical and Biological Aspects of Curcumin: A Review. The Natural Products Journal. 11(3). 318–343. 3 indexed citations
18.
Arya, Preeti, et al.. (2019). Green tea: Chemical composition, biological effects and health benefits. Asian Journal of Pharmacy and Pharmacology. 5(2). 227–234. 3 indexed citations
19.
Guarve, Kumar, et al.. (2018). Formulation and evaluation of controlled porosity osmotic pump-based tablet of tramadol hydrochloride. Asian Pacific Journal of Health Sciences. 5(2). 170–176.
20.
Guarve, Kumar & Ghanshyam Das Gupta. (2009). DEVELOPMENT AND IN VITRO EVALUATION OF OSMOTICALLY CONTROLLED ORAL DRUG DELIVERY SYSTEM OF CARVEDILOL. International Journal of Pharmaceutical Sciences and Drug Research. 80–82. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026